Pasar al contenido principal

DIANAS PARA EL DISEÑO DE NUEVOS FARMACOS PARA REGENERAR LESIONES CEREBRALES ISQUEMICAS

PID2022-142418OB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CADIZ

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Reparación de lesiones corticales: dianas, mecanismos y oportunidades terapéuticas

  • Carrascal, Livia
  • Domínguez García, Samuel
  • Gómez Oliva, Ricardo
  • Pardillo Díaz, Ricardo
  • Pérez García, Patricia
  • Ortego Domínguez, María
  • Chamorro Francisco, Andrea
  • Vázquez de Górgolas, Sonia
  • Martínez-Gómez, Nora
  • Nunez Abades, Pedro
  • Castro González, Carmen
Las lesiones cerebrales de diversas etiologías cursan con una pérdida irreversible de neuronas que conlleva la aparición de déficits cognitivos motores y sensoriales. El conocimiento de los mecanismos de reemplazo neuronal en el cerebro adulto ha abierto las puertas al desarrollo de nuevas terapias relacionadas con la promoción de la neurogénesis en lesiones cerebrales. En este trabajo queremos destacar el papel de la vía de señalización ADAM17/TGFα/EGFR como diana terapéutica para el desarrollo de fármacos dirigidos a potenciar la neurogénesis en lesiones cerebrales. Mostramos la función que cada una de estas moléculas desempeña en la creación de un nicho no-neurogénico en los alrededores de la lesión y mostramos como el bloqueo de esta vía mediante varios agentes farmacológicos, puede ser una herramienta terapéutica para promover la regeneración de lesiones cerebrales.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Mathematical modeling of neuroblast migration toward the olfactory bulb

  • Acosta Soba, Daniel
  • Castro González, Carmen
  • Geribaldi Doldán, Noelia
  • Guillén González, Francisco
  • Nunez Abades, Pedro
  • Ortega Román, Noelia
  • Pérez García, Patricia
  • Rodríguez Galván, José Rafael
This article is devoted to the mathematical modeling of the migration of neuroblasts, precursor cells of neurons, along the Rostral Migratory Stream (RMS), the pathway they usually follow before maturing. According to our model, this way is determined mainly by attraction forces to the olfactory bulb, and also by the heterogeneous mobility of neuroblasts in different regions of the brain. Carefully identifying them as solutions to partial differential equations allows us to determine the movement of neuroblasts along the RMS in a realistic fashion. For solving the equations we develop numerical schemes where the application of novel discontinuous Galerkin methods allows to maintain the properties of the continuous model such as the maximum principle. We present some successful computer tests including parameter adjustment to fit real data from rodent brains.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulating effects of creatine prevent sex-dependent hippocampal neuroinflammation, neuronal damage, and electrophysiological dysfunction induced by chronic colitis

  • Ruiz-Calero, Alejandro
  • Ortego-Domínguez, Marta
  • Vázquez-Carretero, María D.
  • Sotelo-Parrilla, Gema
  • Martínez-Gómez, Nora
  • Calonge, María L.
  • Pardillo-Díaz, Ricardo
  • Castro, Carmen
  • Nuñez-Abades, Pedro
  • Peral, María J.
  • Carrascal, Livia
  • García-Miranda, Pablo
Chronic inflammation in inflammatory bowel disease (IBD) disrupts the gut-brain axis, thereby inducing abnormal immune responses in the brain that are increasingly recognized as a source of neurological comorbidities. In the present work, we investigated the structural integrity and electrophysiological function of hippocampal cornu ammonis 1 (CA1) pyramidal neurons in a rat model of ulcerative colitis induced by dextran sulfate sodium administration. Moreover, given the known neuroprotective properties of the nutraceutical creatine, we aimed to determine whether its oral supplementation prevents or mitigates hippocampal alterations caused by chronic colitis. In both, we also examined the sex differences. Our findings reveal that male rats exhibited a greater colitis-induced hippocampal neuroinflammation, while microglial activation does not differ between sexes. Males developed a markedly altered hippocampal phenotype characterized by significant CA1 neuronal damage, reduced intrinsic excitability reflected by increased rheobase, remodeled inward and outward membrane current profiles and upregulation of a key ion channel such as Kv2.1. In contrast, females displayed a substantially milder phenotype, showing conserved neuronal integrity and electrophysiological properties despite molecular changes including increased Cav1.2. This indicates that the magnitude of hippocampal damage correlates with the severity of colitis-induced neuroinflammation, which differs between sexes. Significantly, creatine supplementation was highly effective in both sexes and prevented colitis-induced hippocampal neuroinflammation, microglial activation, neuronal damage, and electrophysiological dysfunction. The supplementation restored hippocampal creatine levels, preserved neuronal integrity, and normalized impaired excitability. This protective action is exerted only on those parameters altered by colitis, suggesting that the seemingly smaller effect of creatine in females is due to their lower initial pathological burden. Our results indicate a pronounced hippocampal vulnerability of males to chronic colitis and establish creatine as a promising, potent neuromodulator to prevent inflammation-driven brain dysfunction., This work was supported by the I + D + I grants: PID2019-105632RB-I00 funded by MCIN/AEI//https://doi.org/10.13039/501100011033, PID2023-147372OB-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by ERDF/EU, and PID2022-142418OB-C21 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by ERDF/UE., Peer reviewed